These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6368429)

  • 1. 2-Acetylpyridine thiosemicarbazones and Mycobacterium leprae.
    Shepard CC; Klayman DL; Scovill JP; Morrison NE
    Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):7-9. PubMed ID: 6368429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined chemotherapy against Mycobacterium leprae in the mouse.
    Pattyn SR; Van Loo G
    Ann Soc Belg Med Trop; 1980 Sep; 60(3):291-5. PubMed ID: 7018423
    [No Abstract]   [Full Text] [Related]  

  • 3. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
    Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimycobacterial activity of 2-acetylpyridine thiosemicarbazones in relation to their antileprosy activity.
    Morrison NE; Collins FM
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):180-6. PubMed ID: 7196888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
    Dhople AM; Ibanez MA
    Arzneimittelforschung; 1994 Apr; 44(4):563-5. PubMed ID: 8011013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat.
    Fieldsteel AH; Levy L
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of cycloserine and structurally related compounds against M. leprae-infected mice.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):536-8. PubMed ID: 6399071
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of the combination of isoniazid, protionamide and dapsone against Mycobacterium leprae and some other mycobacteria.
    Pattyn SR; Portaels F; Van Loo G; Van den Breen L
    Arzneimittelforschung; 1981; 31(12):2155-7. PubMed ID: 7037011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoside-bearing liposomal delivery systems against macrophage-associated disorders involving Mycobacterium leprae and Mycobacterium tuberculosis.
    Medda S; Das N; Mahato SB; Mahadevan PR; Basu MK
    Indian J Biochem Biophys; 1995 Jun; 32(3):147-51. PubMed ID: 7590855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of thiacetazone, thiambutosine, thiocarlide and sulphamethoxypyridazine against Mycobacterium leprae in mice.
    Colston MJ; Hilson GR; Ellard GA; Gammon PT
    Lepr Rev; 1978 Jun; 49(2):101-13. PubMed ID: 78428
    [No Abstract]   [Full Text] [Related]  

  • 12. Prothionamide and prothionamide-S-oxide in experimental leprosy.
    Matsuo Y; Tatsukawa H; Murray JF; Peters JH
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):302-6. PubMed ID: 6459296
    [No Abstract]   [Full Text] [Related]  

  • 13. Dosage and site of entry influence growth and dissemination of Mycobacterium leprae in T900r mice.
    Ebenezer GJ; Arumugam S; Job CK
    Int J Lepr Other Mycobact Dis; 2002 Dec; 70(4):245-9. PubMed ID: 12768925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of thiozamin (p-(p'-aminobenzenesulfonyl)-benzaldehyde thiosemicarbazone) against Mycobacterium leprae infections in mice.
    Matsuo Y
    Jpn J Microbiol; 1971 Jan; 15(1):93-4. PubMed ID: 4927841
    [No Abstract]   [Full Text] [Related]  

  • 16. Class specific anti-Mycobacterium leprae antibody assay in lepromatous leprosy (BL-LL) patients during the first two to four years of DDS treatment.
    Melsom R; Harboe M; Naafs B
    Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):271-81. PubMed ID: 6754639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
    Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
    Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of Mycobacterium leprae immunity in severe combined immunodeficient mice using a T-cell line.
    Azouaou N; Gelber RH; Abel K; Sasaki DT; Murray LP; Locksley RM; Mohagheghpour N
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):398-405. PubMed ID: 8228438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.